At a glance
ClinicalIndex Comparison RecordN/ACompleted· 150 enrolled
Drug / intervention
Cigarettes +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PROJECT 4: CLINICAL TRIAL METHODS FOR ASSESSING A TOBACCO PRODUCT Part of "MODELS FOR TOBACCO PRODUCT EVALUATION
In Brief
A clinical study evaluating Cigarettes and Snus for Smoker. Completed, enrolled 150 participants across 3 sites.
Detailed Summary
Cigarette smokers who are eligible will enter a Camel Snus sampling phase. Smokers interested in continuing with the study after the sampling phase will undergo a 2 week baseline assessment phase and will then be randomized to one of the three experimental conditions for 8 weeks. Tobacco use patterns, subjective responses to product, and nicotine and toxicant exposure will be assessed.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoker
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJun 2013
Enrollment StartJul 2013
Primary CompletionFeb 2017
Study CompletionMay 2018
TodayJul 2026
First PostedJun 3, 2013
Enrollment StartJul 1, 2013
Primary CompletionFeb 1, 2017
Study CompletionMay 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 13.1 years ago
Interventions
Cigarettesother
Smoke their usual brand of cigarettes and follow their normal patterns of use.
Snusother
Winterchill or Robust flavors